Exploring the Glycosylation of Serum CA125

Ovarian cancer is the most lethal gynaecologic cancer affecting women. The most widely used biomarker for ovarian cancer, CA125, lacks sensitivity and specificity. Here, we explored differences in glycosylation of CA125 between serum from patients with ovarian cancer and healthy controls. We found d...

Descripción completa

Detalles Bibliográficos
Autores principales: Saldova, Radka, Struwe, Weston B., Wynne, Kieran, Elia, Giuliano, Duffy, Michael J., Rudd, Pauline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759877/
https://www.ncbi.nlm.nih.gov/pubmed/23896595
http://dx.doi.org/10.3390/ijms140815636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759877/
https://www.ncbi.nlm.nih.gov/pubmed/23896595
http://dx.doi.org/10.3390/ijms140815636

Ejemplares similares